Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Giloralimab (Anti-TNFRSF5 / CD40) For research use only.
Not for use in humans.

Giloralimab (Anti-TNFRSF5 / CD40)

Synonyms: ABBV-927

Giloralimab (Anti-TNFRSF5 / CD40) is an agonistic monoclonal antibody directed against the B-cell surface antigen CD40 with potential antineoplastic activity. MW: 145.26 KD.

Giloralimab (Anti-TNFRSF5 / CD40)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Giloralimab (Anti-TNFRSF5 / CD40) is an agonistic monoclonal antibody directed against the B-cell surface antigen CD40 with potential antineoplastic activity. MW: 145.26 KD.

Product Details

CAS No. 2226292-20-0
Molecular Weight 145.26
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Giloralimab (Anti-TNFRSF5 / CD40) | Giloralimab (Anti-TNFRSF5 / CD40) supplier | purchase Giloralimab (Anti-TNFRSF5 / CD40) | Giloralimab (Anti-TNFRSF5 / CD40) cost | Giloralimab (Anti-TNFRSF5 / CD40) manufacturer | order Giloralimab (Anti-TNFRSF5 / CD40) | Giloralimab (Anti-TNFRSF5 / CD40) distributor